Seroma Clinical Trial
Official title:
Excision of Strip of Deep Fascia to Reduce Seroma Formation and Extrusion of Tissue Expanders
Tissue expansion has enjoyed a wide range of applications since the technique was
popularized in the latter quarter of the last century. During the expansion process,
subcutaneous fat liquefies, skin becomes thinner, muscles atrophy, blood inflow increases,
and lymphatics get occluded. All these factors predispose to seroma formation and implant
extrusion.
A similar problem occurred with lymphoedema patients, and one of the lines of treatment was
creation of a connection to the deep lymphatics to facilitate absorption of accumulated
fluid. The same principle is to be extrapolated to patients having tissue expanders inserted
in the neck and limbs and its effect is to be noted on the incidence of seroma .
The techniques of tissue expansion have been used for many years to expand normal skin
adjacent to the site of a defect. Initially described by Neuman in 1953, it gained
widespread popularity in the eighth decade of the last century after the work of Radovan,
and has been progressively popular since.
The physiology of prolonged tissue expansion was not just a matter of stretching skin, but
the actual formation of additional new skin which had all the attributes of the original
tissue. Austad et al. postulated that tissue expansion caused a decrease in cell density in
the basal layer of the skin and that cell density might regulate skin mitotic activity. A
lower cell density resulted in a greater cell proliferation, resulting in growth of
additional skin. Inflation of the tissue expander was found to cause a threefold elevation
of epidermal mitotic activity within 24 hours, followed by a gradual return to normal
baseline over 2 to 5 days. Conversely, deflation of the expander caused a transient decrease
in epidermal mitotic activity. The increase in mitosis returned to normal 4 weeks after
expansion.
The dermis and subcutaneous tissues were thinned as a result of tissue expansion leading to
an overall decrease in tensile strength of the expanded skin (5-7) and this persisted 36
weeks after expansion. The subcutaneous layer of fat was intolerant to stretching causing
significant thinning. With faster expansion, fat necrosis could be seen. Pressure necrosis
on subcutaneous fat led to liquefaction and seroma formation. With progression of expansion
compression of superficial lymphatics resulted in their occlusion and lymph accumulation.
Furthermore, the muscle layer in pigs, which was similar to the platysmal layer in humans,
tended to atrophy with maximal expansion. As expansion proceeded, there was an increase in
the number and size of the blood vessels within flaps supplied by random-pattern vessels
and, if present, axial vessels. These changes corresponded to the demonstrated increase in
blood flow to expanded flaps. In the study by Saxby this lead to surviving lengths after
expansion being 50 percent greater than the delayed controls, and nearly 150 percent greater
than comparable flaps raised acutely.
These histologic and physiologic findings would explain the high incidence of seroma
formation with tissue expanders especially those inserted in areas rich in subcutaneous fat,
such as the neck and limbs. During the expansion process, subcutaneous fat liquefies, skin
becomes thinner, muscles atrophy, blood inflow increases, and lymphatics get occluded. All
these factors when coupled with the fact that mere presence of a foreign body incites fluid
exudation would be a frank invitation for seroma formation and implant extrusion.
Reported rates of seroma varied in the literature between 5-18%. Its effect ranged from
minor complications that that did not interrupt the expansion process or require any
operative intervention (32%) up to major complications that required additional operative
intervention (12%).
Opinions differed between authors regarding seroma prevention. Several authors omit use of
drainage procedures to prevent infection. Others use closed suction drains but there was an
increased risk of infection; and seromas tended to occur following their removal.
External filling ports might drain seromas through the entry port, but at the risk of
increased infection rates (19). Over inflation of the expanders to obliterate any dead space
came with the risk of overlying skin ischemia and necrosis.
As a projection to the hypothesis of Thompson on lymphoedema management, this study was
performed to find the effect of opening new drainage channels between the superficial and
deep lymphatics on the incidence of seroma formation.
;
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT04496180 -
Prevena to Prevent Surgical Site Infection After Emergency Abdominal Laparotomy
|
N/A | |
Completed |
NCT03650868 -
The Effect of Thoracal Paravertebral Block on Seroma Reduction in Breast Surgery
|
N/A | |
Completed |
NCT03665883 -
Use of Diathermy Versus Blunt Dissection in TEP for Inguinal Hernia
|
N/A | |
Completed |
NCT02668588 -
Extended-release of Octreotide (LF-PB) for the Treatment of Seroma
|
Phase 2 | |
Completed |
NCT01454713 -
Retrospective Analysis of Veritas in Breast Reconstruction
|
N/A | |
Not yet recruiting |
NCT04471142 -
Effectiveness of Compressive Bandage Use in Seroma Prevention
|
N/A | |
Not yet recruiting |
NCT02967627 -
VAC Dressings for Colorectal Resections
|
N/A | |
Recruiting |
NCT03598712 -
Local Compression Seroma DIminution Objective (CLODIS)
|
Phase 3 | |
Completed |
NCT04666051 -
Fibrin Glue in Inguinal Lymphadenectomy
|
N/A | |
Recruiting |
NCT01454167 -
Acid Base and Electrolytes Patterns in Drains Operational Wounds and Its Relation to Complications
|
N/A | |
Completed |
NCT01112735 -
Efficacy and Safety of ARTISS for Flap Adherence in Abdominoplasty
|
Phase 2 | |
Completed |
NCT03647930 -
The Effect of Arista on Post-Operative Bleeding and Wound Drainage Following Mastectomy
|
N/A | |
Recruiting |
NCT05509829 -
EvaLuating negAtive pressUre Wound theRapy in brEast coNserving Surgery
|
N/A | |
Terminated |
NCT04818580 -
Progressive Tension Sutures in Gender Affirming Mastectomy
|
N/A | |
Withdrawn |
NCT02568085 -
Trial Evaluating Use of Arista in Total Thyroidectomy
|
N/A | |
Active, not recruiting |
NCT01942707 -
Scarpa´s Fascia in the Formation of Seroma Post Abdominoplasty After Bariatric Surgery
|
N/A | |
Recruiting |
NCT03167944 -
Traditional Electrosurgery System Versus Low Thermal Tissue Dissection System for Total Mastectomy
|
N/A | |
Recruiting |
NCT03190876 -
Seroma Prevention After Body Contouring Procedures
|
N/A | |
Completed |
NCT03590704 -
Safety of the Use of Compressive Taping in Seroma
|
N/A | |
Recruiting |
NCT04035590 -
Seroma Reduction and Drain Free Mastectomy
|
N/A |